737
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Pharmaceuticals of emerging concern in hospital wastewater: removal of Ibuprofen and Ofloxacin drugs using MBBR method

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, & show all
Pages 140-154 | Received 14 Jul 2020, Accepted 15 Nov 2020, Published online: 21 Dec 2020
 

ABSTRACT

Hospital wastewater (HWW) is one of the largest sources of pharmaceutical release. The present paper proposes the sustainable and controllable hospital wastewater treatment method based on the photo-Fenton process using MnO2 and moving bed biofilm reactor (MBBR) treatment followed by ozonation process. The method has satisfactory removal rates of Ibuprofen and Ofloxacin˃90%. Evaluation of the optimum operational parameters such as hydraulic retention time (HRT), mixed liquor suspended solids (MLSS), ozone consumption (OC), time of ozone exposure (TOE), manganese oxide (MnO2) concentration (MOC) was carried out. It was established that the optimal performance occurred at following conditions – HRT (16–20 hours), MLSS (2500–3500 mg/L), OC (7–9 L/hrs), TOE (4–10 min) and MOC (1.9–2.7 mg/L). It is proposed for practical application to control the HWW in two stages. The first stage includes preliminary tests for evaluation of optimum MOC. The second stage is based on continuous evaluation of HRT and TOE using analytical modelling functions.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.